Biolife Solutions Stock Z Score

BLFS Stock

USD 20.76 0.07 0.34%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out BioLife Solutions Piotroski F Score and BioLife Solutions Valuation analysis.

For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.

Build AI portfolio with BioLife Stock

At this time, BioLife Solutions' Capital Surpluse is comparatively stable compared to the past year. Additional Paid In Capital is likely to gain to about 87.9 M in 2025, whereas Net Working Capital is likely to drop slightly above 73.4 M in 2025. At this time, BioLife Solutions' Non Operating Income Net Other is comparatively stable compared to the past year.

BioLife Solutions Company Z Score Analysis

BioLife Solutions' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Z Score

Sum Of

5 Factors

More About Z Score | All Equity Analysis

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

BioLife Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for BioLife Solutions is extremely important. It helps to project a fair market value of BioLife Stock properly, considering its historical fundamentals such as Z Score. Since BioLife Solutions' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of BioLife Solutions' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of BioLife Solutions' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Net Receivables	Short Term Debt	Short Term Investments	Common Stock	Current Deferred Revenue	Intangible Assets	Property Plant Equipment	Long Term Debt	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Accumulated Depreciation	Long Term Debt Total	Long Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.63	-0.44	-0.79	0.81	0.95	0.96	0.87	0.81	0.52	0.36	0.63	0.64	0.97	0.5	0.98	0.94	0.89	-0.6	-0.44	0.73	0.44	0.99	0.91	0.97
Total Stockholder Equity	0.63		-0.71	-0.5	0.23	0.45	0.62	0.21	0.58	-0.26	0.2	0.39	0.53	0.64	-0.1	0.68	0.65	0.62	-0.4	-0.5	0.37	0.51	0.61	0.57	0.61
Net Debt	-0.44	-0.71		0.33	-0.03	-0.18	-0.58	-0.04	-0.36	0.2	-0.02	-0.31	-0.31	-0.48	0.4	-0.51	-0.62	-0.53	0.45	0.56	-0.49	-0.35	-0.4	-0.61	-0.43
Retained Earnings	-0.79	-0.5	0.33		-0.42	-0.78	-0.85	-0.6	-0.95	-0.56	-0.32	-0.23	-0.08	-0.89	-0.53	-0.83	-0.85	-0.79	0.54	0.66	-0.66	-0.78	-0.75	-0.77	-0.87
Accounts Payable	0.81	0.23	-0.03	-0.42		0.85	0.67	0.96	0.44	0.65	0.28	0.72	0.77	0.68	0.59	0.73	0.64	0.63	-0.48	0.07	0.55	-0.08	0.85	0.66	0.73
Total Liab	0.95	0.45	-0.18	-0.78	0.85		0.88	0.92	0.79	0.66	0.45	0.61	0.54	0.92	0.75	0.92	0.85	0.8	-0.47	-0.31	0.69	0.39	0.95	0.84	0.94
Total Current Assets	0.96	0.62	-0.58	-0.85	0.67	0.88		0.77	0.83	0.54	0.34	0.58	0.46	0.97	0.43	0.97	0.99	0.91	-0.64	-0.56	0.83	0.53	0.93	0.96	0.96
Net Receivables	0.87	0.21	-0.04	-0.6	0.96	0.92	0.77		0.57	0.79	0.31	0.68	0.61	0.78	0.69	0.79	0.74	0.71	-0.52	-0.07	0.67	0.09	0.88	0.74	0.82
Short Term Debt	0.81	0.58	-0.36	-0.95	0.44	0.79	0.83	0.57		0.42	0.37	0.14	0.19	0.91	0.52	0.87	0.81	0.73	-0.4	-0.74	0.56	0.84	0.77	0.73	0.86
Short Term Investments	0.52	-0.26	0.2	-0.56	0.65	0.66	0.54	0.79	0.42		0.16	0.36	0.06	0.52	0.69	0.46	0.5	0.47	-0.39	-0.02	0.6	0.09	0.53	0.53	0.56
Common Stock	0.36	0.2	-0.02	-0.32	0.28	0.45	0.34	0.31	0.37	0.16		0.1	0.15	0.38	0.52	0.36	0.29	0.3	0.21	-0.16	0.26	0.27	0.38	0.35	0.4
Current Deferred Revenue	0.63	0.39	-0.31	-0.23	0.72	0.61	0.58	0.68	0.14	0.36	0.1		0.68	0.5	0.24	0.55	0.61	0.62	-0.54	0.22	0.55	-0.25	0.67	0.65	0.58
Intangible Assets	0.64	0.53	-0.31	-0.08	0.77	0.54	0.46	0.61	0.19	0.06	0.15	0.68		0.46	0.1	0.58	0.47	0.46	-0.41	0.1	0.35	-0.23	0.67	0.48	0.48
Property Plant Equipment	0.97	0.64	-0.48	-0.89	0.68	0.92	0.97	0.78	0.91	0.52	0.38	0.5	0.46		0.5	0.99	0.96	0.89	-0.55	-0.6	0.72	0.62	0.95	0.91	0.98
Long Term Debt	0.5	-0.1	0.4	-0.53	0.59	0.75	0.43	0.69	0.52	0.69	0.52	0.24	0.1	0.5		0.46	0.36	0.35	-0.03	-0.04	0.39	0.23	0.52	0.38	0.54
Net Tangible Assets	0.98	0.68	-0.51	-0.83	0.73	0.92	0.97	0.79	0.87	0.46	0.36	0.55	0.58	0.99	0.46		0.95	0.85	-0.57	-0.54	0.73	0.54	0.97	0.91	0.97
Capital Surpluse	0.94	0.65	-0.62	-0.85	0.64	0.85	0.99	0.74	0.81	0.5	0.29	0.61	0.47	0.96	0.36	0.95		0.94	-0.69	-0.56	0.8	0.51	0.91	0.95	0.95
Deferred Long Term Liab	0.89	0.62	-0.53	-0.79	0.63	0.8	0.91	0.71	0.73	0.47	0.3	0.62	0.46	0.89	0.35	0.85	0.94		-0.65	-0.5	0.68	0.44	0.84	0.87	0.88
Accumulated Depreciation	-0.6	-0.4	0.45	0.54	-0.48	-0.47	-0.64	-0.52	-0.4	-0.39	0.21	-0.54	-0.41	-0.55	-0.03	-0.57	-0.69	-0.65		0.21	-0.61	-0.05	-0.57	-0.61	-0.56
Long Term Debt Total	-0.44	-0.5	0.56	0.66	0.07	-0.31	-0.56	-0.07	-0.74	-0.02	-0.16	0.22	0.1	-0.6	-0.04	-0.54	-0.56	-0.5	0.21		-0.3	-0.85	-0.33	-0.41	-0.45
Long Term Investments	0.73	0.37	-0.49	-0.66	0.55	0.69	0.83	0.67	0.56	0.6	0.26	0.55	0.35	0.72	0.39	0.73	0.8	0.68	-0.61	-0.3		0.28	0.74	0.86	0.75
Short Long Term Debt	0.44	0.51	-0.35	-0.78	-0.08	0.39	0.53	0.09	0.84	0.09	0.27	-0.25	-0.23	0.62	0.23	0.54	0.51	0.44	-0.05	-0.85	0.28		0.38	0.42	0.55
Net Invested Capital	0.99	0.61	-0.4	-0.75	0.85	0.95	0.93	0.88	0.77	0.53	0.38	0.67	0.67	0.95	0.52	0.97	0.91	0.84	-0.57	-0.33	0.74	0.38		0.92	0.97
Net Working Capital	0.91	0.57	-0.61	-0.77	0.66	0.84	0.96	0.74	0.73	0.53	0.35	0.65	0.48	0.91	0.38	0.91	0.95	0.87	-0.61	-0.41	0.86	0.42	0.92		0.94
Capital Stock	0.97	0.61	-0.43	-0.87	0.73	0.94	0.96	0.82	0.86	0.56	0.4	0.58	0.48	0.98	0.54	0.97	0.95	0.88	-0.56	-0.45	0.75	0.55	0.97	0.94

Click cells to compare fundamentals

To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.

Competition

Predict BioLife Solutions

In accordance with the company's disclosures, BioLife Solutions has a Z Score of 0.0. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.

BioLife Solutions Current Valuation Drivers

We derive many important indicators used in calculating different scores of BioLife Solutions from analyzing BioLife Solutions' financial statements. These drivers represent accounts that assess BioLife Solutions' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of BioLife Solutions' important valuation drivers and their relationship over time.

	2020	2021	2022	2023	2024	2025 (projected)
Market Cap	1.1B	1.4B	773.2M	710.4M	1.2B	1.3B
Enterprise Value	1.0B	1.4B	797.4M	717.7M	1.1B	1.2B

BioLife Solutions ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, BioLife Solutions' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to BioLife Solutions' managers, analysts, and investors.

Environmental

Governance

Social

BioLife Solutions Institutional Holders

Institutional Holdings refers to the ownership stake in BioLife Solutions that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of BioLife Solutions' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing BioLife Solutions' value.

		Shares
William Blair Investment Management, Llc	2025-03-31	946.6 K
Dimensional Fund Advisors, Inc.	2025-03-31	920.3 K
Geode Capital Management, Llc	2025-03-31	887.3 K
Royce & Associates, Lp	2025-03-31	860.7 K
Geneva Capital Management	2025-03-31	852.1 K
Massachusetts Financial Services Company	2025-03-31	764.7 K
Royal Bank Of Canada	2025-03-31	698.3 K
Cramer Rosenthal Mcglynn Llc	2025-03-31	684.4 K
Bank Of America Corp	2025-03-31	574.4 K
Casdin Capital, Llc	2025-03-31	8.7 M
Blackrock Inc	2025-03-31	5.5 M

BioLife Fundamentals

	Return On Equity	-0.0252
	Return On Asset	-0.0079
	Profit Margin	(0.12) %
	Operating Margin	(0.05) %
	Current Valuation	934.78 M
	Shares Outstanding	47.84 M
	Shares Owned By Insiders	2.84 %
	Shares Owned By Institutions	97.16 %
	Number Of Shares Shorted	4.47 M
	Price To Earning	173.59 X
	Price To Book	2.83 X
	Price To Sales	11.32 X
	Revenue	82.25 M
	Gross Profit	57.22 M
	EBITDA	1.53 M
	Net Income	(20.18 M)
	Cash And Equivalents	46.55 M
	Cash Per Share	1.09 X
	Total Debt	30.17 M
	Debt To Equity	0.06 %
	Current Ratio	3.55 X
	Book Value Per Share	7.42 X
	Cash Flow From Operations	8.43 M
	Short Ratio	7.48 X
	Earnings Per Share	(0.19) X
	Price To Earnings To Growth	65.38 X
	Target Price	31.22
	Number Of Employees	159
	Beta	1.82
	Market Capitalization	993.06 M
	Total Asset	399.49 M
	Retained Earnings	(335.1 M)
	Working Capital	116.03 M
	Current Asset	6.97 M
	Current Liabilities	1.73 M
	Net Asset	399.49 M

About BioLife Solutions Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze BioLife Solutions's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioLife Solutions using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioLife Solutions based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for BioLife Stock Analysis

When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Biolife Solutions Stock Z Score

BioLife Solutions Company Z Score Analysis

Z Score

Sum Of

5 Factors

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

BioLife Z Score Driver Correlations

BioLife Solutions Current Valuation Drivers

BioLife Solutions ESG Sustainability

BioLife Solutions Institutional Holders

BioLife Fundamentals

About BioLife Solutions Fundamental Analysis

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for BioLife Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY